Mounjaro®
Starting from £179.99/mo
Start journey Learn moreConstipation is one of the more common bowel changes people notice when they start Mounjaro (tirzepatide). It tends to appear in the first few weeks of treatment, particularly after a dose increase, as the body adjusts to the medicine slowing gastric emptying. The NHS tirzepatide medicines page lists constipation as a common side effect, meaning it affects roughly 1 in 10 or more people taking it. That doesn't make it trivial, but it does mean you're not alone, and in most cases it's manageable. Like all Prescription-Only Medicines, Mounjaro requires a clinical assessment before it is prescribed; a prescriber considers your full health picture, including how your digestive system is likely to respond.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro works partly by reducing how quickly food moves from your stomach into your small intestine. That slowing effect is useful for appetite control, but it ripples further along the gut. The colon receives less frequent signals to move its contents along, stool spends longer in the large bowel, more water is drawn out of it, and the result is harder, less frequent stools. This is physiology, not something going wrong. One misconception worth letting go is the idea that constipation on Mounjaro means the medicine isn't working properly, there's no truth to that. The two are unrelated. Bowel frequency varies enormously between people anyway; what matters clinically is whether you're comfortable and whether things change significantly from your baseline.
The effect is often most noticeable in weeks two to four of a new dose, then settles. If you want to understand why Mounjaro causes constipation and how the gut mechanics behind it work, that guide covers the physiology in detail. And if you want to understand how this fits into the broader experience of treatment, including what side effects look like alongside weight loss results before and after starting Mounjaro, that guide covers the full picture in one place.
Hydration is the first thing to look at. Tirzepatide can reduce thirst signals alongside appetite signals, so it's easy to drink less than usual without noticing. Stools harden directly when fluid intake drops, so a deliberate increase in water throughout the day (not just at mealtimes) makes a real difference for many people. Aim for pale urine as a rough guide rather than counting millilitres.
Dietary fibre is the second lever. Smaller portions on Mounjaro mean total fibre intake often falls even if the proportion in each meal is the same. Adding vegetables, oats, lentils, or ground linseed to whatever you are eating can compensate. If you increase fibre suddenly, do it gradually to avoid bloating on top of constipation. Physical movement helps too, even a 20-minute walk after meals prompts the colon to contract. Most people find that combining all three (fluid, fibre, movement) resolves mild constipation within a week or two without needing anything else. If you want more targeted advice, our guide on how to stop constipation on Mounjaro goes through each approach in more detail.
If those measures aren't enough, a pharmacist can advise on osmotic laxatives like macrogol (Movicol), which soften stool by drawing water into the bowel. Stimulant laxatives are generally avoided long-term; discuss with your prescriber if you feel you need them regularly. A prescriber at a service like nume (sorry, a service like ours) can factor bowel changes into your ongoing clinical review.
Most constipation on Mounjaro is uncomfortable rather than dangerous. There are, however, symptoms that need prompt medical assessment. If you develop severe stomach pain that feels like it is spreading to your back, with or without vomiting, seek urgent help. The MHRA's January 2026 Drug Safety Update for GLP-1 medicines specifically flagged acute pancreatitis as a known but infrequent complication that can be serious; that pattern of pain is one of its indicators. Don't wait to see if it passes.
You should also speak to a doctor or contact your prescriber if constipation is accompanied by blood in your stool, if you go more than five or six days without any bowel movement despite self-care measures, or if you develop significant bloating with nausea that isn't resolving. These aren't common, but they're the signals that move constipation from a manageable nuisance into something worth investigating. You can read more about how Mounjaro constipation typically presents, what tends to help, and when to seek further advice, including how often different symptoms appear across the clinical trials.
Any suspected side effect, whether serious or not, can be reported to the MHRA through the Yellow Card scheme. Patient reports genuinely contribute to post-market safety monitoring for newer medicines like Mounjaro, which carries a Black Triangle (▼) status indicating it is subject to additional MHRA scrutiny.
Before any dose increase, a prescriber should know how your gut has been behaving at the current dose. If constipation has been persistent, unresolved or uncomfortable, that's relevant clinical information, not a complaint to keep to yourself. At nume (at a service like ours) every repeat order is clinically reviewed before dispatch, which is the moment to flag it. There's no separate appointment needed; it's part of the process.
For context on how the overall Mounjaro experience fits together, the main Mounjaro treatment guide covers eligibility, how treatment is titrated and what the clinical evidence shows. If you're still deciding whether this is the right route for you, checking your eligibility with our prescribers is free and includes a discussion of your individual risk profile and how side effects like this are managed. Our prescribers discuss both suitability and likely side effects as a core part of every consultation, not as an afterthought.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.